Dehydroepiandrosterone: Is there a role for replacement?

被引:55
作者
Dhatariya, KK [1 ]
Nair, KS [1 ]
机构
[1] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA
关键词
D O I
10.4065/78.10.1257
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dehydroepiandrosterone (DHEA) and its sulfated ester are found in high concentrations in the plasma; however, their role in normal human physiology, other than as precursors for sex hormones, remains incompletely defined. Studies of rodent models have shown that these hormones have beneficial effects on a wide variety of conditions, such as diabetes, obesity, immune function, atherosclerosis, and many of the disorders associated with normal aging. However, rodents are not the best models to study the actions of these hormones because they have very little endogenous DHEA; thus, the doses given to these animals are usually suprapharmacological. Human studies have been performed to determine the potential beneficial effects of DHEA replacement in persons with low DHEA levels. Results have been I conflicting. Human studies suggest a potential role for DHEA replacement in persons who have undergone adrenalectomy and possibly in the aging population. However, long-term studies assessing the benefits vs adverse effects must be done before DHEA replacement can be recommended.
引用
收藏
页码:1257 / 1273
页数:17
相关论文
共 177 条
  • [121] DEHYDROEPIANDROSTERONE REDUCES SERUM LOW-DENSITY LIPOPROTEIN LEVELS AND BODY-FAT BUT DOES NOT ALTER INSULIN SENSITIVITY IN NORMAL MEN
    NESTLER, JE
    BARLASCINI, CO
    CLORE, JN
    BLACKARD, WG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (01) : 57 - 61
  • [122] THE RELATION BETWEEN CALCIUM-ABSORPTION, SERUM DEHYDROEPIANDROSTERONE, AND VERTEBRAL MINERAL DENSITY IN POSTMENOPAUSAL WOMEN
    NORDIN, BEC
    ROBERTSON, A
    SEAMARK, RF
    BRIDGES, A
    PHILCOX, JC
    NEED, AG
    HOROWITZ, M
    MORRIS, HA
    DEAM, S
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 60 (04) : 651 - 657
  • [123] Dehydroepiandrosterone decreases mortality rate and improves cellular immune function during polymicrobial sepsis
    Oberbeck, R
    Dahlweid, M
    Koch, R
    van Griensven, M
    Emmendörfer, A
    Tscherne, H
    Pape, HC
    [J]. CRITICAL CARE MEDICINE, 2001, 29 (02) : 380 - 384
  • [124] Adrenal insufficiency
    Oelkers, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (16) : 1206 - 1212
  • [125] AGE-CHANGES AND SEX-DIFFERENCES IN SERUM DEHYDROEPIANDROSTERONE SULFATE CONCENTRATIONS THROUGHOUT ADULTHOOD
    ORENTREICH, N
    BRIND, JL
    RIZER, RL
    VOGELMAN, JH
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1984, 59 (03) : 551 - 555
  • [126] Quality control of dehydroepiandrosterone dietary supplement products
    Parasrampuria, J
    Schwartz, K
    Petesch, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18): : 1565 - 1565
  • [127] Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus - A double-blind, randomized, placebo-controlled trial
    Petri, MA
    Lahita, RG
    van Vollenhoven, RF
    Merrill, JT
    Schiff, M
    Ginzler, EM
    Strand, V
    Kunz, A
    Gorelick, KJ
    Schwartz, KE
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (07): : 1820 - 1829
  • [128] Prough RA, 1995, ANN NY ACAD SCI, V774, P187
  • [129] Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease
    Rasmuson, S
    Näsman, B
    Carlström, K
    Olsson, T
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2002, 13 (02) : 74 - 79
  • [130] Dehydroepiandrosterone in the treatment of erectile dysfunction: A prospective, double-blind, randomized, placebo-controlled study
    Reiter, WJ
    Pycha, A
    Schatzl, G
    Pokorny, A
    Gruber, DM
    Huber, JC
    Marberger, M
    [J]. UROLOGY, 1999, 53 (03) : 590 - 594